Future

Celltrion showcases the competitiveness of its autoimmune treatment Remsima SC at Europe's largest gastroenterology conference.

Democratic Party lawmaker Kim Kyo-heung is calling for a dedicated national suicide prevention fund, arguing that per-death spending on suicide prevention is just one-240th of traffic safety spending and urging coordinated support for vulnerable young people, including those facing isolation, addiction and mental health crises.

Yoo Han Corp. R&D chief Kim Yeol-hong says the company’s next century should be built around repeatedly developing new drugs by deepening expertise in selected fields, adopting new technologies and attracting global talent.

Yoo Han Corp. R&D chief Kim Yeol-hong said the company expects follow-up drug development results by year-end while continuing to build a broad pipeline through both internal research and external acquisitions.

Alteogen has secured a European composition patent for the subcutaneous formulation combining its ALT-B4 enzyme with Merck’s Keytruda, strengthening intellectual property protection for the product in Europe.